Caseware UK (AP4) 2024.0.164 2024.0.164 2024-06-302024-06-30false22023-07-01falseNo description of principal activity2truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 09629942 2023-07-01 2024-06-30 09629942 2022-07-01 2023-06-30 09629942 2024-06-30 09629942 2023-06-30 09629942 c:Director1 2023-07-01 2024-06-30 09629942 c:Director2 2023-07-01 2024-06-30 09629942 d:OfficeEquipment 2024-06-30 09629942 d:OfficeEquipment 2023-06-30 09629942 d:ComputerEquipment 2023-07-01 2024-06-30 09629942 d:CurrentFinancialInstruments 2024-06-30 09629942 d:CurrentFinancialInstruments 2023-06-30 09629942 d:CurrentFinancialInstruments d:WithinOneYear 2024-06-30 09629942 d:CurrentFinancialInstruments d:WithinOneYear 2023-06-30 09629942 d:ShareCapital 2024-06-30 09629942 d:ShareCapital 2023-06-30 09629942 d:RetainedEarningsAccumulatedLosses 2024-06-30 09629942 d:RetainedEarningsAccumulatedLosses 2023-06-30 09629942 c:FRS102 2023-07-01 2024-06-30 09629942 c:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 09629942 c:FullAccounts 2023-07-01 2024-06-30 09629942 c:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 09629942 2 2023-07-01 2024-06-30 09629942 e:PoundSterling 2023-07-01 2024-06-30 iso4217:GBP xbrli:pure

Registered number: 09629942










QUINTESSENTIAL HEALTH LAB LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 JUNE 2024

 
QUINTESSENTIAL HEALTH LAB LIMITED
REGISTERED NUMBER: 09629942

BALANCE SHEET
AS AT 30 JUNE 2024

2024
2023
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 5 
98,900
102,123

  
98,900
102,123

Creditors: amounts falling due within one year
 6 
(112,761)
(113,452)

Net current liabilities
  
 
 
(13,861)
 
 
(11,329)

Total assets less current liabilities
  
(13,861)
(11,329)

  

Net liabilities
  
(13,861)
(11,329)


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
(13,961)
(11,429)

  
(13,861)
(11,329)


Page 1

 
QUINTESSENTIAL HEALTH LAB LIMITED
REGISTERED NUMBER: 09629942

BALANCE SHEET (CONTINUED)
AS AT 30 JUNE 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 25 April 2025.




I Anosike
P Anosike
Director
Director

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
QUINTESSENTIAL HEALTH LAB LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

1.Accounting policies

 
1.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
1.2

Going concern

The company ceased trading on 08 April 2021 and is no longer a going concern.

 
1.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
1.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
1.5

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
1.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Computer equipment
-
3 years straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
1.7

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 3

 
QUINTESSENTIAL HEALTH LAB LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

1.Accounting policies (continued)

 
1.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


2.


General information

Quintessential Health Lab Limited is a private limited company incorporated in England and Wales. The Registered Office is 38 Sheringham Avenue, London N14 4UG.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).


4.


Tangible fixed assets





Computer equipment

£



Cost or valuation


At 1 July 2023
600



At 30 June 2024

600



Depreciation


At 1 July 2023
600



At 30 June 2024

600



Net book value



At 30 June 2024
-



At 30 June 2023
-

Page 4

 
QUINTESSENTIAL HEALTH LAB LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

5.


Debtors

2024
2023
£
£


Other debtors
98,900
102,123

98,900
102,123



6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank overdrafts
1,962
1,948

Bank loans
40,109
40,109

Trade creditors
6,807
7,144

Corporation tax
63,883
64,251

112,761
113,452



7.


Transactions with directors

During the previous years, the company made an advance to I & P Anosike, directors of the company. Interest amounting to £1,656 has been charged to the directors. £73,159 remained outstanding at 30th June 2024.


Page 5